These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 6883360)
41. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M; J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458 [TBL] [Abstract][Full Text] [Related]
42. Letter: Chemotherapy of Hodgkin's disease. Winokur SH N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438 [No Abstract] [Full Text] [Related]
43. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E; Kende G; Many A; Ramot B Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
44. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449 [TBL] [Abstract][Full Text] [Related]
45. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy of malignant lymphoma]. Horikoshi N; Ogawa M Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187 [TBL] [Abstract][Full Text] [Related]
47. Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease? Mauch P; Hellman S Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):947-9. PubMed ID: 7204134 [No Abstract] [Full Text] [Related]
48. Combination chemotherapy of Hodgkin disease in children. Kolygin BA; Fedoreev GA Neoplasma; 1975; 22(2):225-30. PubMed ID: 1161118 [TBL] [Abstract][Full Text] [Related]
49. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)]. Sampi K; Honda T; Hattori M Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984 [No Abstract] [Full Text] [Related]
50. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Fisher RI; DeVita VT; Hubbard SP; Simon R; Young RC Ann Intern Med; 1979 May; 90(5):761-3. PubMed ID: 434676 [TBL] [Abstract][Full Text] [Related]
51. Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial. Yelle L; Bergsagel D; Basco V; Brown T; Bush R; Gillies J; Israels L; Miller A; Rideout D; Whitelaw D J Clin Oncol; 1991 Nov; 9(11):1983-93. PubMed ID: 1941057 [TBL] [Abstract][Full Text] [Related]
52. Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy. Cimino G; Biti GP; Cartoni C; Magrini SM Eur J Cancer; 1992; 28A(11):1853-5. PubMed ID: 1389525 [TBL] [Abstract][Full Text] [Related]
53. [Multiple drug treatment of Hodgkin's disease: the MOPP schedule]. Singer Z; Dzieza-Lalowicz I; Kardaszewicz S; Rozek-Lesiak K Nowotwory; 1978; 28(2):203-8. PubMed ID: 683884 [No Abstract] [Full Text] [Related]
54. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118 [TBL] [Abstract][Full Text] [Related]
55. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis]. Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767 [No Abstract] [Full Text] [Related]
56. Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. van Rijswijk RE; Haanen C; Dekker AW; de Meijer AJ; Verbeek J J Clin Oncol; 1989 Dec; 7(12):1776-82. PubMed ID: 2585019 [TBL] [Abstract][Full Text] [Related]
57. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone. Givens SS; Fuller LM; Hagemeister FB; Gehan EA Cancer; 1990 Jul; 66(1):69-74. PubMed ID: 2354411 [TBL] [Abstract][Full Text] [Related]